“Gene Therapy”

6 result(s)
Pipeline Therapies Could Expand Choices for Conditions with Limited Options | Payor Solutions | CVS Health
Drug Pipeline
Pipeline Therapies Could Expand Choices for Conditions with Limited Options
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Drug Pipeline
A Thriving Pipeline Expected to Continue Expanding Treatment Options
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Cost Management
Solutions to Mitigate the Cost of Gene Therapies
CVS Health offers payors a new stop-loss program and installment payment plan to help mitigate the large one-time impact of costly gene therapies. These approaches are part of... More
Briefing
View article
Drug Pipeline
Gene Therapies for Cancer, Hemophilia on the Horizon
Updates on the robust gene therapy pipeline from CVS Health pipeline team to help payors stay abreast of this very important emerging category. More
Briefing
Drug Pipeline
Two New Treatments for Sickle Cell Disease
New drugs likely to offer patients more options. Key consideration for payors will be effectively balancing high — and rising — price tags with appropriate access. More
Feature
Cost Management
White Paper: Gene Therapy
Gene therapies have the potential to relieve tremendous suffering for patients with genetic disorders and together we can find ways to ensure these treatments are accessible for... More
White Paper